Table 3 Cox proportional hazard regression model* for BV risk factors.

From: Epidemiology of Breakthrough Varicella after the Implementation of a Universal Varicella Vaccination Program in Taiwan, 2004–2014

 

Hazard ratio

95% CI

Female vs. male

0.85

0.83–0.87

Varivax® vs. Varilrix®

0.75

0.72–0.78

Age at vaccination (month)

1.13

1.09–1.17

  1. *Stratified by county of residence and calendar year at vaccination.
Back to article page